Join us on top of Kilimanjaro and help us find a Cure for CML

September 2018 -2019 marks the 10th anniversary of the International CML Foundation. By joining Climb for a Cure: Mount Kilimanjaro 2019, you will not only celebrate this landmark anniversary with us, you will play an integral role in getting us closer to a cure for CML. Mt Kilimanjaro can be climbed. Chronic Myeloid Leukemia can be cured. You can be part of it.

Will you join us?

Learn more about the Climb for a cure challenge, how you’ll make a difference and how to register

November 2017 - If you are coming to the annual American Society of Hematology meeting (ASH) you are invited to attend this year’s iCMLf Forum for Physicians from Emerging Regions that will take place on December 8th, from 12.30 pm - 2.00 pm in the Doubletree Downtown Atlanta, Georgia, USA.

This year’s iCMLf Forum, presented in partnership with The Max Foundation, focuses on ‘Perspectives on the Management of CML’. The meeting includes presentations from; Associate Professor Sue Branford (Australia), Dr Elza Lomaia (Russia), Professor Susanne Saussele (Germany), and Dr Katia Pagnano (Brazil) on the topics Molecular Monitoring of CML and Treatment Free Remission.

‘I have applied MS Anderson’s guidelines on our patients in Vietnam to help them be more aware of the disease and compliance with treatment’ (Dr Dung, Vietnam)

October 2017 - The Annual Report 2016/2017 features the iCMLf activities from Sept. 1st 2016 to August 31st 2017.
Read more on the highlights in the iCMLf Annual Report 2016/2017 here:

iCMLf Virtual Education Program - Now also available in Russian

September 2018 - To make the iCMLf Virtual Education Program more accessible for physicians from non-English speaking countries, the iCMLf also presents modules in Spanish and French. Now we are delighted to offer two new presentations in Russian.

Dr Elza Lomaia from the Almazov Medical Research Centre in St. Petersburg, Russia, discusses CML treatment and side effects, along with monitoring and treatment free remission.

CML highlights from EHA 2018 – treatment options in resistant CML patients, the role of IFN- α in the TKI era and treatment free remission

August 2018 - As part of our educational service, we are delighted to present to you three new expert talks that were first presented during the 23rd Congress of the European Hematology Association. These presentations cover different aspects on CML management like treatment options in resistant CML patients, the role of IFN- α in the TKI era and TFR as a potential new treatment goal.

Treatment options in resistant CML patients
(Professor Jane Apperley, London)

Does IFN- α improve outcome of CML in the TKI era?
(Dr Franck-Emmanuel Nicolini, Paris)

TFR – a new treatment goal of CP-CML patients?
(Dr Delphine Réa, Paris)

Fun Run Group Picture Kopie

October 2017 - Early in the morning at 7am, before the Sunday sessions and just a few hours before the Lisbon marathon passed by, participants of the 19th John Goldman Conference on CML – all dressed up in green ‘John Goldman Fun Run’ T-Shirts – started to run along the beautiful Estoril promenade. Despite the early hour everyone had a big smile in their faces enjoying the sea view and the sunrise.

Again this year, all this was for a good cause: by purchasing a bright green ‘iCMLf John Goldman Fund’ running T-Shirt participants supported the training of young physicians from the emerging regions.

Page 28 of 38

Copyright © 2023 All Rights Reserved. The iCMLf is registred as charity no. 1132984 in England and Wales
Registered Address: International CML Foundation - 20 Eversley Road - Bexhill-On-Sea, East Sussex, TN40 1HE - UK